DK1146889T3 - Identifikation af specifikke differentielt udtrykte mycobakterielle antigener og medicinsk anvendelse af Mycobakteriumproteinerne Rv0068 og Rv3407 - Google Patents
Identifikation af specifikke differentielt udtrykte mycobakterielle antigener og medicinsk anvendelse af Mycobakteriumproteinerne Rv0068 og Rv3407Info
- Publication number
- DK1146889T3 DK1146889T3 DK00904979T DK00904979T DK1146889T3 DK 1146889 T3 DK1146889 T3 DK 1146889T3 DK 00904979 T DK00904979 T DK 00904979T DK 00904979 T DK00904979 T DK 00904979T DK 1146889 T3 DK1146889 T3 DK 1146889T3
- Authority
- DK
- Denmark
- Prior art keywords
- relates
- mycobacterium
- differentially expressed
- identification
- present
- Prior art date
Links
- 241000186359 Mycobacterium Species 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99101590 | 1999-01-29 | ||
PCT/EP2000/000690 WO2000044392A2 (en) | 1999-01-29 | 2000-01-28 | Identification of specific differentially expressed mycobacterial antigens |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1146889T3 true DK1146889T3 (da) | 2007-10-22 |
Family
ID=8237440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00904979T DK1146889T3 (da) | 1999-01-29 | 2000-01-28 | Identifikation af specifikke differentielt udtrykte mycobakterielle antigener og medicinsk anvendelse af Mycobakteriumproteinerne Rv0068 og Rv3407 |
Country Status (10)
Country | Link |
---|---|
US (1) | US7772386B1 (da) |
EP (1) | EP1146889B1 (da) |
JP (1) | JP2002534994A (da) |
AT (1) | ATE366583T1 (da) |
AU (1) | AU2667600A (da) |
CA (1) | CA2361246C (da) |
DE (1) | DE60035485T2 (da) |
DK (1) | DK1146889T3 (da) |
ES (1) | ES2288842T3 (da) |
WO (1) | WO2000044392A2 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2135947A1 (en) * | 2008-06-17 | 2009-12-23 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Antagonists of bacterial sequences |
ITRM20100411A1 (it) * | 2010-07-23 | 2012-01-24 | Massimo Amicosante | Uso di sequenze amminoacidiche da mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino. |
EP3293254B1 (en) * | 2014-03-07 | 2020-11-18 | Institute for Systems Biology | Point of care assays to detect the status of tuberculosis infection |
US11679150B2 (en) * | 2020-03-03 | 2023-06-20 | The United States Of America, As Represented By The Secretary Of Agriculture | Mycoplasma bovis vaccine product |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
KR102405798B1 (ko) * | 2020-06-22 | 2022-06-08 | 주식회사 미코라파 | Rv2882c-Rv2005c 융합 단백질을 포함하는 결핵 면역 치료용 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2624759B2 (ja) * | 1988-03-30 | 1997-06-25 | 味の素株式会社 | Bcg菌由来のmpb64蛋白及びその製造法 |
FR2752425B1 (fr) | 1996-08-19 | 1998-11-13 | Pasteur Institut | Fragments d'acides nucleiques specifiques de mycobacteries membres du complexe m. tuberculosis et leurs applications pour la detection et le diagnostic differentiel des membres du complexe m. tuberculosis |
-
2000
- 2000-01-28 AT AT00904979T patent/ATE366583T1/de not_active IP Right Cessation
- 2000-01-28 DE DE60035485T patent/DE60035485T2/de not_active Expired - Lifetime
- 2000-01-28 AU AU26676/00A patent/AU2667600A/en not_active Abandoned
- 2000-01-28 US US09/890,339 patent/US7772386B1/en not_active Expired - Fee Related
- 2000-01-28 EP EP00904979A patent/EP1146889B1/en not_active Expired - Lifetime
- 2000-01-28 CA CA2361246A patent/CA2361246C/en not_active Expired - Lifetime
- 2000-01-28 WO PCT/EP2000/000690 patent/WO2000044392A2/en active IP Right Grant
- 2000-01-28 JP JP2000595694A patent/JP2002534994A/ja active Pending
- 2000-01-28 DK DK00904979T patent/DK1146889T3/da active
- 2000-01-28 ES ES00904979T patent/ES2288842T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7772386B1 (en) | 2010-08-10 |
ES2288842T3 (es) | 2008-02-01 |
ATE366583T1 (de) | 2007-08-15 |
DE60035485D1 (de) | 2007-08-23 |
JP2002534994A (ja) | 2002-10-22 |
WO2000044392A3 (en) | 2000-12-07 |
WO2000044392A2 (en) | 2000-08-03 |
AU2667600A (en) | 2000-08-18 |
DE60035485T2 (de) | 2008-03-20 |
EP1146889A2 (en) | 2001-10-24 |
CA2361246A1 (en) | 2000-08-03 |
EP1146889B1 (en) | 2007-07-11 |
CA2361246C (en) | 2013-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brandt et al. | New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population | |
Hanff et al. | Humoral immune response in human syphilis to polypeptides of Treponema pallidum. | |
JP4283872B2 (ja) | 微生物蛋白質と、この蛋白質を産生する微生物と、該蛋白質のワクチンおよび結核検出での利用 | |
AP1027A (en) | Protein K resistant surface protein of neisseria meningitidis. | |
AU2005214061B2 (en) | Polypeptides for inducing a protective immune response against Staphylococcus aureus | |
DE60139690D1 (de) | Immunisierung gegen chlamydia pneumoniae | |
BRPI0208301A8 (pt) | vacinas de ácido nucléico para prevenção de infecção por flavivírus | |
Okay et al. | Immunogenicity and protective efficacy of the recombinant Pasteurella lipoprotein E and outer membrane protein H from Pasteurella multocida A: 3 in mice | |
ATE406912T1 (de) | Immunisierung gegen chlamydia tracheomatis | |
Reglinski et al. | Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG | |
ATE526994T1 (de) | Mtb32a antigen aus mycobakterium tuberculosis mit inaktivierter protease aktivität und fusionsproteine die das antigen enthalten | |
FI895050A0 (fi) | Diagnostiska preparat och vaccin foer mykobakterier i folkhaelso-, medicinsk och veterinaermedicinsk praxis. | |
DE60144201D1 (de) | Lawsonia intracellularis Impfstoff | |
Prado et al. | Immunogenicity of iron-regulated outer membrane proteins of Pasteurella multocida A: 3 in cattle: molecular characterization of the immunodominant heme acquisition system receptor (HasR) protein | |
JP2009051859A (ja) | 非型性のヘモフィルスインフルエンザ(Haemophilusinfluenzae)株用のワクチンとしての精製非型性ヘモフイルスインフルエンザP5蛋白質 | |
JP2017513860A (ja) | 新規結核菌(m.tuberculosis)ワクチン | |
Paul et al. | Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model | |
Whitlock et al. | Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge | |
Sharma et al. | Immune response characterization and vaccine potential of a recombinant chimera comprising B-cell epitope of Aeromonas hydrophila outer membrane protein C and LTB | |
Huang et al. | Immunization with cell‐free‐generated vaccine protects from Porphyromonas gingivalis‐induced alveolar bone loss | |
Hashemzehi et al. | Cloning and expression of nlpA gene as DNA vaccine candidate against Acinetobacter baumannii | |
Cho et al. | Extracellular vesicle-associated antigens as a new vaccine platform against scrub typhus | |
DK1146889T3 (da) | Identifikation af specifikke differentielt udtrykte mycobakterielle antigener og medicinsk anvendelse af Mycobakteriumproteinerne Rv0068 og Rv3407 | |
WO2004020609A3 (en) | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection | |
Chelliah et al. | Potential DNA vaccine for haemorrhagic septiceamia disease |